Simona Lattanzi Selected Research

Relapsing-Remitting Multiple Sclerosis

9/2021	Potential prognostic value of circulating inflamma-miR-146a-5p and miR-125a-5p in relapsing-remitting multiple sclerosis.
11/2017	Persistence to oral disease-modifying therapies in multiple sclerosis patients.
11/2015	Prediction of disability progression in fingolimod-treated patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simona Lattanzi Research Topics

Disease

42	Epilepsy (Aura) 05/2024 - 01/2018
36	Seizures (Absence Seizure) 04/2024 - 04/2015
18	Stroke (Strokes) 12/2023 - 01/2013
15	Partial Epilepsies (Epilepsy, Partial) 04/2024 - 04/2016
10	Sleepiness 09/2021 - 10/2018
9	Status Epilepticus (Complex Partial Status Epilepticus) 02/2024 - 01/2018
7	Drug Resistant Epilepsy 12/2023 - 10/2018
7	Ischemic Stroke 07/2022 - 07/2016
6	Lennox Gastaut Syndrome 01/2023 - 10/2018
5	Myoclonic Epilepsies (Myoclonic Encephalopathy) 10/2023 - 01/2020
5	Multiple Sclerosis 01/2023 - 08/2017
4	Cerebral Hemorrhage 07/2022 - 01/2018
4	Hematoma 05/2021 - 01/2017
4	Diarrhea 01/2021 - 10/2018
3	Idiopathic Generalized Epilepsy 05/2024 - 11/2023
3	Inflammation (Inflammations) 02/2024 - 01/2018
3	Neoplasms (Cancer) 02/2023 - 11/2021
3	Migraine Disorders (Migraine) 01/2023 - 03/2019
3	Temporal Lobe Epilepsy 01/2023 - 11/2019
3	Brain Injuries (Brain Injury) 01/2022 - 01/2020
3	Relapsing-Remitting Multiple Sclerosis 09/2021 - 11/2015
3	Pathologic Constriction (Stenosis) 01/2020 - 01/2018
2	Hemorrhagic Stroke 12/2023 - 11/2020
2	Juvenile Myoclonic Epilepsy 11/2023 - 01/2021
2	Brain Neoplasms (Brain Tumor) 02/2023 - 01/2023
2	Epileptic Syndromes 01/2023 - 01/2018
2	Cognitive Dysfunction 01/2023 - 01/2021
2	Brain Diseases (Brain Disorder) 12/2022 - 01/2021
2	Head and Neck Neoplasms (Head and Neck Cancer) 10/2022 - 01/2022
2	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2022 - 01/2020
2	Cerebral Infarction 06/2022 - 11/2020
2	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 01/2021
2	Complex Partial Epilepsy (Psychomotor Epilepsy) 01/2022 - 11/2019
2	COVID-19 12/2021 - 10/2020
2	Postoperative Pain 11/2021 - 01/2020
2	Absence Epilepsy (Childhood Absence Epilepsy) 01/2021 - 01/2019
2	Dizziness (Lightheadedness) 01/2021 - 11/2020
2	Diplopia (Double Vision) 01/2021 - 11/2020
2	Anorexia 01/2020 - 10/2018
2	Ataxia (Dyssynergia) 01/2020 - 10/2018
2	Disease Progression 04/2018 - 11/2015
2	Parkinson Disease (Parkinson's Disease) 04/2018 - 01/2016
1	Neurodevelopmental Disorders 01/2024
1	Infections 10/2023
1	Fever (Fevers) 10/2023
1	Sleep Deprivation 10/2023

Drug/Important Bio-Agent (IBA)

15	brivaracetamIBA 04/2024 - 04/2016
15	Anticonvulsants (Antiepileptic Drugs)IBA 12/2022 - 04/2016
11	CannabidiolIBA 04/2024 - 10/2018
11	perampanelIBA 01/2024 - 01/2018
7	Lamotrigine (Lamictal)FDA LinkGeneric 05/2024 - 01/2019
7	CenobamateIBA 12/2023 - 11/2020
6	Valproic Acid (Depakote)FDA LinkGeneric 05/2024 - 01/2019
6	Levetiracetam (Keppra)FDA LinkGeneric 05/2024 - 01/2021
6	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022 - 01/2018
5	Lacosamide FDA Link 12/2023 - 04/2015
5	eslicarbazepine acetateIBA 12/2023 - 01/2018
5	Transaminases (Aminotransferases)IBA 01/2021 - 10/2018
4	Immunoglobulin E (IgE)IBA 05/2024 - 01/2021
4	FenfluramineIBA 04/2024 - 05/2022
4	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2016
4	Ethosuximide (Zarontin)FDA LinkGeneric 01/2022 - 01/2019
3	AMPA Receptors (AMPA Receptor)IBA 02/2023 - 01/2018
3	Dimethyl FumarateIBA 01/2023 - 11/2017
3	Clonazepam (Rivotril)FDA LinkGeneric 01/2022 - 11/2019
3	Clobazam (HR 376)IBA 01/2021 - 01/2020
3	Fingolimod Hydrochloride (FTY720)FDA Link 10/2020 - 11/2015
2	AcidsIBA 02/2023 - 01/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 05/2021
2	Calcitonin Gene-Related PeptideIBA 09/2022 - 03/2019
2	Ion Channels (Ion Channel)IBA 05/2022 - 01/2019
2	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2021 - 01/2020
2	C-Reactive ProteinIBA 12/2021 - 01/2018
2	Antidepressive Agents (Antidepressants)IBA 05/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 10/2020
2	Anti-Anxiety Agents (Anxiolytics)IBA 05/2021 - 01/2020
2	Phenobarbital (Luminal)FDA Link 01/2020 - 01/2020
2	Phenytoin (Dilantin)FDA LinkGeneric 01/2020 - 01/2020
2	CholesterolIBA 01/2020 - 04/2015
2	Zonisamide (Zonegran)FDA LinkGeneric 01/2020 - 10/2018
2	BenzodiazepinesIBA 01/2020 - 12/2019
1	Topiramate (Topamax)FDA LinkGeneric 01/2024
1	stiripentolIBA 10/2023
1	soticlestatIBA 10/2023
1	Glutamic Acid (Glutamate)FDA Link 02/2023

Therapy/Procedure

26	Therapeutics 04/2024 - 04/2015
4	Drug Therapy (Chemotherapy) 10/2023 - 06/2022
3	Laminectomy 11/2021 - 01/2020
3	Carotid Endarterectomy 01/2020 - 01/2018
2	Aftercare (After-Treatment) 05/2023 - 09/2021
2	Radiotherapy 10/2022 - 01/2022
2	Thrombolytic Therapy 12/2021 - 12/2020
2	Length of Stay 11/2021 - 12/2020
2	Thrombectomy 01/2021 - 01/2020
1	Cesarean Section (Caesarean Section) 05/2024
1	Postnatal Care 05/2024
1	Induced Labor 05/2024
1	Airway Management 02/2024
1	Secondary Prevention 12/2023
1	Inappropriate Prescribing 10/2023